Home 2023

Cancer testing

European Commission Orders Illumina to Divest of Grail
Industry News

European Commission Orders Illumina to Divest of Grail

Alex Philippidis -
0
Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval
News

Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval

Alex Philippidis -
0
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Close to the Edge

Carl Icahn States His Case for Change at Illumina on “Close to the Edge”

Alex Philippidis -
23
AACR News: GRAIL Validates Methylation-Based Cancer Detection Test
Cancer

AACR News: GRAIL Validates Methylation-Based Cancer Detection Test

Julianna LeMieux, PhD -
0
StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight
GEN Edge

StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight

Alex Philippidis -
0
Exclusive: RBC Analyst Weighs in on Icahn’s Proxy Battle for Illumina
Insights

Exclusive: RBC Analyst Weighs in on Icahn’s Proxy Battle for Illumina

Alex Philippidis -
0
Strata Oncology Validates Clinical Utility of Solid Tumor Predictive Biomarker
Cancer

Strata Oncology Validates Clinical Utility of Solid Tumor Predictive Biomarker

Anjali A. Sarkar, PhD -
0
CRISPR Tech Lights Up Cancer Biomarker miRNAs in Plasma Exosomes
Cancer

CRISPR Tech Lights Up Cancer Biomarker miRNAs in Plasma Exosomes

Sophia Ktori -
0
At JPM, Illumina Announces African-American Sequencing Collaboration
Cancer

At JPM, Illumina Announces African-American Sequencing Collaboration

Alex Philippidis -
0
Test May Predict Recurrence and Response to Immunotherapy in Melanoma Patients
Cancer

Test May Predict Recurrence and Response to Immunotherapy in Melanoma Patients

Anjali A. Sarkar, PhD -
0
123...5Page 1 of 5
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.